USA :The EU secures 300 million vaccines from a French laboratory

European Comission has reached a principle of agreement Sanofi to ensure the purchase of 300 million doses of a future “safe and effective” vaccine against COVID-19 developed by the French pharmaceutical group, the community institution has reported. “data-reactid =” 17 “> The European Commission has arrived to a principle of Sanofi agreement to ensure the purchase of 300 million doses of a future “safe and effective” vaccine against COVID-19 developed by the French pharmaceutical group, the community institution has reported.

Specifically, Brussels has finalized “exploratory talks” with Sanofi that will result in an Advance Purchase Agreement once the pharmaceutical group manages to develop an effective vaccine against the disease.

When this happens, the European Commission will enjoy a “contractual framework” from which all Member States will be able to benefit from acquiring doses of this future vaccine.

The head of the Community Executive, Ursula von der Leyen, stressed that this agreement is an “important first step” in the framework of the European strategy for the coronavirus vaccine. “There will be more news soon,” the German has predicted in a statement, in which she assured that Brussels also maintains “advanced” contacts with other firms. “Data-reactid =” 20 “> The head of the Community Executive, Ursula von der Leyen stressed that this agreement is an “important first step” in the framework of the European strategy for the coronavirus vaccine. “There will be more news soon,” the German predicted in a statement, in which she assured that Brussels also maintains “advanced” contacts with other firms.

“Although we do not know today which vaccine will work best, Europe is investing in a diversified portfolio of promising vaccines based on various types of technologies. This increases our options to quickly obtain an effective solution against the virus ”, highlighted Von der Leyen.

The European Commission has taken advantage of this preliminary agreement to recall that it is prepared to “explore with international partners” the option that an “important” group of countries agree to “accumulate resources” to create a “joint stock” of future vaccines, both for them as for the less wealthy countries.

“Rich countries can act as a group of active buyers, thus accelerating the development of safe and effective vaccines and maximizing access to them by everyone in need in the world,” said Brussels.

YOU MAY ALSO LIKE

Spain hopes to test its first coronavirus vaccine in humans in December“data-reactid =” 27 “> Spain expects to test its first coronavirus vaccine in humans in December

The ring vaccine method: how it could be applied when you arrive in Spain“data-reactid =” 28 “> The ring vaccine method: how it could be applied when you arrive in Spain

Fernando Simón, on vaccines: “We could consider eliminating the virus”“data-reactid =” 29 “> Fernando Simón, on vaccines:” We could consider eliminating the virus “

The HuffPost and has been updated.“data-reactid =” 30 “> This article originally appeared on The HuffPost and has been updated.